What difference does a matte chip bag make? What part of your brain pushed for that deodorant brand? Felix Cao says your primal brain most likely had a say. He describes how neuroscience and business marketing strategies have propelled ways to measure brain activity and affect our buying choices. Listen and learn How nueromarketing has tapped into a panicking consumer mindset during the pandemic to target our need for security, What role nostalgia is playing in today's marketing, How the primal brain acts as a filter for the logical part and why, and What are examples of effective marketing decisions that have led to definitive business growth strategies. Felix Cao specializes in neuromarketing and is the founder of Happy Buying Brain. He brought a long-time fascination with how the visual affects our brain with the latest in neuroscience and technology into the founding of his company. Because he helps companies apply brain activity measurements to more effective selling campaigns, he has fascinating stories about why and how our brains react differently to seemingly innocuous details, like metallic versus matte packaging to the impact of aroma vapors on a soup can. With artificial intelligence, machine learning, and virtual reality breakthroughs, advertising science is on the verge of a whole new set of methods. Meanwhile, Cao explains, because smartphone use has rapidly increased, neuromarketers have their hands full with studying effects of screen size and scrolling habits. It all starts with evolutionary biology, he says, and the human impulse to scan for the best opportunity is closely aligned with our survival instinct. That's where nueromarketers come in, finding ways to engage with that instinct so that it filters to the logical part of the brain. Listen in for ideas toward great marketing science and a better understanding of how our brains make these daily decisions. For more about his work, see Happy Buying Brain. Episode also available on Apple Podcasts: apple.co/30PvU9C ... https://www.youtube.com/watch?v=XmntBpLph_c

Our Website: https://www.findinggeniuspodcast.com/ Subscribe and review our Podcast on iTunes: https://apple.co/2L6tN88 Follow us on: Facebook: https://web.facebook.com/futuretechpodcast/ Twitter: https://twitter.com/finding_genius Instagram: https://www.instagram.com/findinggeniuspodcast/ LinkedIn: https://www.linkedin.com/company/finding-genius-podcast/ Dr. George Calin holds M.D. and Ph.D. degrees from Carol Davila University of Medicine in Bucharest, Romania. He completed cancer genomics training at the University of Ferrara in Italy and was a post-doctor fellow at the Kimmel Center in Pennsylvania. The focus of his work is exploring new RNA therapeutic options for cancer patients. Click on play to learn: 1. Why research on non-coding RNAs is important and what makes them special. 2. How studies of ultraconserved gene sequences led to the discovery of distinct signatures in human cancers. 3. How combinatorial therapeutics for small RNAs shows promise in treating cancers. Dr. Calin is the Principal Investigator at the Calin Laboratory at MD Anderson. He is currently working on all aspects of molecular biology and biomarkers with a focus on deadly cancers such as ovarian, gastric, colon, pancreatic, and cholangiocarcinoma. It has become evident in recent cancer research that the genomic complexity of cancer cells is more significant than originally assumed. For more than 30 years, the focus was on the development and testing of new gene therapy strategies involving protein-coding genes. The research done by Dr. Calin and his colleagues has led to the concept that small non-coding RNAs knowns as microRNA genes (miRNAs) are involved in the production of human tumors. His research also showed that another family of ncRNAs, ultraconserved genes (UCGs) plays a role in cancer initiation, progression, and the mechanisms of a predisposition to cancer. Looking to the future, the results of the studies of miRNAs and ncRNAs has led to the possibilities of combinatorial therapeutics that are customized for a specific cancer patient. Dr. Calin believes that there is a strong need to focus on the early diagnosis of cancer which has the potential to increase the survival of cancer patients significantly. To learn more visit: mdanderson.org/research Episode also available on Apple Podcasts: apple.co/30PvU9C #cancer #microRNA #noncodingRNA #genes #genetics #RNA #genomics #biomarkers #Findinggeniuspodcast #Healthpodcast #InternalMedicinepodcast #Biosciencespodcast ... https://www.youtube.com/watch?v=noi4N07eoz4